Tag: trial

0 0 0 Comment
Posted in HEADLINES

Edesa Biotech shares jump 14% premarket after early review of COVID treatment finds it should continue trial

Edesa Biotech Inc. shares EDSA, -2.11% jumped 14% premarket on Friday, after the Canadian biotech, which is listed on Nasdaq,…

0 0 0 Comment
Posted in HEADLINES

Moderna says trial booster vaccine effective against COVID-19 variants

Moderna Inc. MRNA, -6.19% stock rose more than 1% in the extended session Wednesday after the biotechnology company said that…

0 0 0 Comment
Posted in HEADLINES

Emergent says experimental COVID-19 treatment failed in Phase 3 trial

Emergent BioSolutions Inc. EBS, -13.40% said Friday that its experimental COVID-19 treatment did not demonstrate a clinical benefit in a…

0 0 0 Comment
Posted in HEADLINES

Senate backtracks on calling witnesses in Trump’s second impeachment trial

The Senate on Saturday afternoon backtracked on its earlier move to have witnesses in former President Donald Trump’s impeachment trial,…

0 0 0 Comment
Posted in HEADLINES

Closing arguments start in Trump’s second impeachment trial

Closing arguments began on Saturday afternoon in the Senate for former President Donald Trump’s second impeachment trial, putting the chamber…

0 0 0 Comment
Posted in HEADLINES

Senate votes 55-45 in favor of calling witnesses in Trump’s second impeachment trial

The Senate on Saturday voted 55 to 45 in favor of calling witnesses in former President Donald Trump’s second impeachment…

0 0 0 Comment
Posted in HEADLINES

Vir, GSK’s experimental COVID-19 treatment moves into a Phase 3 clinical trial

Shares of Vir Biotechnology Inc. VIR, +0.69% gained 1.3% in premarket trading on Friday, the day after the biotech and…

0 0 0 Comment
Posted in HEADLINES

Five Prime’s stock rockets fourfold after positive trial results from cancer treatment, analyst upgrade

Shares of Five Prime Therapeutics Inc. FPRX, -2.73% blasted 314% higher in premarket trading Wednesday, after the company said its…

0 0 0 Comment
Posted in HEADLINES

Bellicum Pharmaceuticals to cut 79% of staff after disappointing trial data, stock suffering record plunge

Shares of Bellicum Pharmaceuticals Inc. BLCM, -37.11% plunged 35.1% in midday trading Friday, putting them on track for their biggest-ever…

0 0 0 Comment
Posted in HEADLINES

WSJ: AstraZeneca can resume COVID-19 vaccine trial in the U.S.

Shares of AstraZeneca AZN, +0.07% were up 0.8% in trading on Friday after a person familiar with the matter told…

0 0 0 Comment
Posted in HEADLINES

Vir’s stock rises as COVID-19 drug moves to late-study clinical trial

Shares of Vir Biotechnology Inc. VIR, +4.62% gained 5.3% in trading on Tuesday after the company said it is expanding…

0 0 0 Comment
Posted in HEADLINES

Regeneron stock higher after news its COVID-19 trial drug given to Trump

Shares of Regeneron Pharmaceuticals Inc. REGN, -0.58% rose more than 2% in the extended session Friday after a White House…